Evidence map›Paper›PMID 36779330›Full record

SynthesisPharmacological reviews2022

Changing Cerebral Blood Flow, Glucose Metabolism, and Dopamine Binding Through Transcranial Magnetic Stimulation: A Systematic Review of Transcranial Magnetic Stimulation-Positron Emission Tomography Literature.

Kaitlin R Kinney, Colleen A Hanlon

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Pharmacological reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Therapeutic Effects of Theta Burst Stimulation on Cognition Following Brain Injury.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kaitlin R KinneyDepartment of Cancer Biology (K.R.K., C.A.H.) and Department of Physiology and Pharmacology (C.A.H.), Wake Forest School of Medicine, Winston-Salem, North Carolina.
Colleen A HanlonDepartment of Cancer Biology (K.R.K., C.A.H.) and Department of Physiology and Pharmacology (C.A.H.), Wake Forest School of Medicine, Winston-Salem, North Carolina chanlon@wakehealth.edu.
Wake Forest University · US

Funding

Wake Forest Translational Alcohol Research Center (WF-TARC)P50AA026117 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Colleen A Hanlon · 2018 to 2026
$16.2M
MULTI-DISCIPLINARY TRAINING IN THE BIOLOGY OF ALCOHOLISMT32AA007565 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BRIAN A MCCOOL · 1994 to 2026
$10.1M
Longitudinal Investigation of TMS as a Tool to Improve Alcohol Treatment OutcomesR01AA027705 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ADDICOTT, MERIDETH A., LAURIENTI, PAUL · 2019 to 2023
$3.4M
Translational approaches to TMS treatment development for smokingR01DA044471 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ADDICOTT, MERIDETH A., BICKEL, WARREN K · 2018 to 2021
$2.5M
NIAAA NIH HHS P50 AA026117NIAAA NIH HHS R01 AA027705NIAAA NIH HHS T32 AA007565NIDA NIH HHS R01 DA044471
6 · The paper itself

Abstract

Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation tool currently used as a treatment in multiple psychiatric and neurologic disorders. Despite its widespread use, we have an incomplete understanding of the way in which acute and chronic sessions of TMS affect various neural and vascular systems. This systematic review summarizes the state of our knowledge regarding the effects TMS may be having on cerebral blood flow, glucose metabolism, and neurotransmitter release. Forty-five studies were identified. Several key themes emerged: 1) TMS transiently increases cerebral blood flow in the area under the coil; 2) TMS to the prefrontal cortex increases glucose metabolism in the anterior cingulate cortex of patients with depression; and 3) TMS to the motor cortex and prefrontal cortex decreases dopamine receptor availability in the ipsilateral putamen and caudate respectively. There is, however, a paucity of literature regarding the effects TMS may have on other neurotransmitter and neuropeptide systems of interest, all of which may shed vital light on existing biologic mechanisms and future therapeutic development. SIGNIFICANCE STATEMENT: Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation tool currently used as a treatment in multiple psychiatric and neurologic disorders. This systematic review summarizes the state of our knowledge regarding the effects TMS on cerebral blood flow, glucose metabolism, and neurotransmitter release.

Indexed as

DopamineTranscranial Magnetic StimulationCerebrovascular CirculationGlucoseHumansPositron-Emission TomographyTomography, X-Ray ComputedDopamineGlucose

Identifiers

PMID36779330
PMCPMC9580100
OpenAlexW4295048178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.